Skip to main content
. 2017 Jun 9;18(6):1240. doi: 10.3390/ijms18061240

Figure 1.

Figure 1

Progression-free (PFS) and overall survival (OS) of mCRC patients treated with CT + B or CT alone: in the overall population (a,b); in those with right-sided tumors (c,d); and in those with left-sided tumors (e,f).